LeMaitre Vascular (LMAT) CEO sells 46,481 shares, retains over 1.4M

Rhea-AI Filing Summary

LeMaitre Vascular Chairman and CEO George W. LeMaitre reported open-market sales of company stock. On May 7 he sold 18,600 shares of common stock at a weighted average price of $107.6351 per share, and on May 8 he sold 27,881 shares at a weighted average price of $108.6905 per share.

After these direct sales, he continued to hold 1,430,019 shares directly. The filing also shows 33,400 shares held indirectly by the “LeMaitre Irrevocable Life Insurance Trust of 2025,” for the benefit of his children, where he disclaims beneficial ownership except for any pecuniary interest.

Insights

Equity compensation and insider-trading analyst

CEO executes modest net stock sale while retaining a large direct stake.

Chairman and CEO George W. LeMaitre reported selling a total of 46,481 common shares in open-market transactions at weighted average prices around $108 per share. These are straightforward Code S sales, with prices reflecting multiple trades within disclosed intraday ranges.

Following the sales, he still directly holds 1,430,019 shares, indicating that only a small portion of his visible direct position was sold. The filing also notes 33,400 shares held by an irrevocable trust for his children, for which he disclaims beneficial ownership except for any pecuniary interest, aligning this with estate and family planning rather than trading intent.

The transaction summary shows two sell transactions, no option exercises, and no tax-withholding or gifting activity, suggesting routine portfolio management rather than a structural change in his equity exposure. Overall, this looks like a normal liquidity event, and by itself does not clearly alter the company’s investment thesis.

Insider Trade Summary

Net Seller: 46,481 shares ($5,032,413)

Net Sell 3 txns

Insider LeMaitre George W

Role Chairman and CEO

Sold 46,481 shs ($5.03M)

Type	Security	Shares	Price	Value
Sale	Common Stock	27,881	$108.6905	$3.03M
Sale	Common Stock	18,600	$107.6351	$2.00M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,430,019 shares (Direct, null); Common Stock — 33,400 shares (Indirect, LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025)

Footnotes (1)

1. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $107.10 to $108.00. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $107.41 to $109.73. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.

Key Figures

Shares sold May 7: 18,600 shares Price per share May 7: $107.6351/share Shares sold May 8: 27,881 shares +4 more

7 metrics

Shares sold May 7 18,600 shares Open-market sale at weighted average price on May 7, 2026

Price per share May 7 $107.6351/share Weighted average sale price; trades ranged $107.10–$108.00

Shares sold May 8 27,881 shares Open-market sale at weighted average price on May 8, 2026

Price per share May 8 $108.6905/share Weighted average sale price; trades ranged $107.41–$109.73

Total shares sold 46,481 shares Net-sell volume across two open-market sale transactions

Direct holdings after sales 1,430,019 shares Common stock directly owned following the May 8, 2026 sale

Indirect trust holdings 33,400 shares Held by LeMaitre Irrevocable Life Insurance Trust of 2025

Key Terms

weighted average price, open-market sale, irrevocable trust, pecuniary interest, +1 more

5 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

irrevocable trust financial

"These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren)."

An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

pecuniary interest financial

"The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any,"

Section 16 regulatory

"shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose."

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LeMaitre George W

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR, INC.

63 SECOND AVENUE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		S		18,600	D	$107.6351(1)	1,457,900	D
Common Stock	05/08/2026		S		27,881	D	$108.6905(2)	1,430,019	D
Common Stock								33,400	I	LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $107.10 to $108.00. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

2. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $107.41 to $109.73. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

3. These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.

	/s/ Laurie A. Churchill, Attorney-in-fact	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did LeMaitre Vascular (LMAT) report for its CEO?

LeMaitre Vascular reported that Chairman and CEO George W. LeMaitre sold company common stock. He executed open-market sales totaling 46,481 shares at weighted average prices around $108 per share, while continuing to hold over 1.4 million shares directly after the transactions.

How many LeMaitre Vascular shares did George W. LeMaitre sell and at what prices?

George W. LeMaitre sold 18,600 shares at a weighted average of $107.6351 and 27,881 shares at a weighted average of $108.6905. Each reported price reflects multiple trades within specified intraday ranges disclosed in the footnotes to the Form 4.

How many LeMaitre Vascular (LMAT) shares does the CEO hold after these Form 4 sales?

After the reported sales, George W. LeMaitre directly holds 1,430,019 shares of LeMaitre Vascular common stock. The Form 4 also shows 33,400 additional shares held indirectly through an irrevocable life insurance trust established for his children’s benefit.

What is the significance of the irrevocable trust mentioned in the LeMaitre Vascular Form 4?

The Form 4 notes 33,400 shares held by the LeMaitre Irrevocable Life Insurance Trust of 2025 for the benefit of his children. The reporting person disclaims ownership of these securities, except for any pecuniary interest, clarifying they are primarily an estate and family-planning vehicle.

Were George W. LeMaitre’s LeMaitre Vascular stock sales part of derivative exercises or tax withholding?

No. The transaction summary shows two open-market sale (Code S) transactions and no option exercises, tax-withholding dispositions, or gifts. This indicates the reported activity reflects direct stock sales rather than option exercises or automatic share withholding for tax purposes.